Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind active-controlled study of Agkistrodon halys antivenin in pit viper bite patients
CTR20262665Phase 2Active
- Sponsor
- Jiangxi Biological Products Research Institute
- Start
- Jul 2026
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of agkistrodon halys antivenin in crotalid envenomation, sponsored by Jiangxi Biological Products Research Institute. Started Jul 2026; status: active.
02
Drugs
agkistrodon halys antivenin
03
Conditions
crotalid envenomation
Beyond the preview
Go deeper on CTR20262665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262665.